SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Eris Lifesciences Emerges as Semaglutide Contender in India

Eris Lifesciences has emerged as a contender in India’s semaglutide market with its Sundae brand, according to the report.

ERIS

Related stories